global developmental delay in children
Conditions
Interventions
2:ketogenic diet therapy
Sponsors
The Third Affiliated Hospital of Zhengzhou University
Eligibility
Sex/Gender
All
Age
No minimum to 5 Years
Inclusion criteria
Inclusion criteria: 1. Pediatric patients with global developmental delay were recruited from June 2016 to December 2016 in the Third Affiliated Hospital of Zhengzhou University Department of rehabilitation of children with GDD, the symptoms of the patient meet the diagnostic criteria of DSM-5 made by American Psychiatric Association; 2. Aged between 6 months old and 5 years old; 3. DQ is less than or equal to 75 and the social life ability scale for children from the infants to middle school students is less than or equal to 8; 4. KD treatment has not been applied in the past 3 months; 5. Informed consent form has been signed when KD treatment is requested or accepted by the patient's parents, included in the study.
Exclusion criteria
Exclusion criteria: 1. Patients with fever or infectious disease of active phase; 2. patients with severe diseases in digestive system, cardiovascular system, respiratory system, urinary system or liver disease or metabolic disease who are not suitable for the research; patients with hyperemesis; 3. Patients with congenital immunodeficiency disease or contraindication for KD treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Gesell Development Schedule Test;Social life ability scale for children from the infants to middle school students;The weight Z-score;The weight Z-score;Side-effect; | — |
Countries
China
Contacts
Public ContactZHU Dengna
The Third Affiliated Hospital of Zhengzhou University
Outcome results
None listed